We then investigated the extent to which long-term Ang II-induced cardiac fibrosis and hypertrophy, as well as cardiac dysfunction, could be suppressed by administration of a chymase specific inhibitor. The gene discussed is CMA1; the disease is cardiac hypertrophy.